Lisco and colleagues published a review of the risks of GLP-1s and thyroid cancer in the journal Endocrine Connections in 2023, and although they describe evidence for a risk of thyroid cancer, they conclude: It is reasonable to continue prescribing GLP-1RAs due to the evidence of more relevant and well-recognized antihyperglycemic, cardiovascular, and renal benefits, with the management staying within current recommendations. If you are considering taking a GLP-1 but are concerned about the risk of thyroid cancer, you should discuss it with your doctor
SACRAMENTO Many low-income Californians prescribed wildly popular weight loss drugs lost their coverage for the medications at the start of the new year
With a focus on pharmacy integration, weight management at Premise helps employers offer evidence-based resources, including GLP-1s where clinically appropriate, that guide members towards better health while managing the ongoing challenges these medications can present
The side effect profiles of semaglutide versus tirzepatide differ enough that switching can help some people
This new agreement might signal the beginning of the end for compounded GLP-1s, both due to legal pressure from the FDA and GLP-1 makers as well as the steady drop in list prices for authorized products, which are now finally close to the prices for compounded versions
The eye test isnt always accurate, but visual changes in your body are often a sign that youre making body composition changes
